Emcure Pharmaceuticals Ltd. - Research Center

---

Results

• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Profit before tax

212.34

616.42

557.45

224.68

369.84

Net cashflow-operating activity

505.37

427.71

774.87

385.25

371.17

Net cash used in investing activity

-270.44

-189.00

-831.16

-164.76

-275.76

Netcash used in fin. activity

-54.52

-342.96

30.97

-45.87

-53.46

Net inc/dec in cash and equivlnt

180.30

-309.06

-29.94

170.45

41.81

Cash and equivalnt begin of year

-393.35

-84.29

-54.35

-224.80

-266.60

Cash and equivalnt end of year

-213.05

-393.35

-84.29

-54.35

-224.80